Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early leukoencephalopathy during daratumumab treatment in a patient with multiple myeloma

Published:2023-02-08 Issue:4 Volume:102 Page:967-969
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Liu Shanshan,Zhou Hongwei,Xu Weiling,Jin Tao,Liang Xinyue,Zhao Xiaoxia,Dai Yun^ORCID,Jin Fengyan^ORCID

Funder

National Natural Science Foundation of China

Jilin Scientific and Technological Development Program

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-023-05120-w.pdf

Reference10 articles.

1. Köhler W, Curiel J, Vanderver A (2018) Adulthood leukodystrophies. Nat Rev Neurol 14:94–105. https://doi.org/10.1038/nrneurol.2017.175

2. Chari A, Attaya Suvannasankha A, Fay JW et al (2017) Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma. Blood 130:974–981. https://doi.org/10.1182/blood-2017-05-785246

3. Monge J, Contreras J, Elsoukkary S et al (2019) Progressive multifocal leukoencephalopathy in a patient with multiple myeloma receiving daratumumab and pomalidomide. Blood 134:4876. https://doi.org/10.1182/blood-2019-122134

4. Kareem SS, Viswanathan N, Sahebjam S et al (2022) Leukoencephalopathy during daratumumab-based therapy: a case series of two patients with multiple myeloma. Onco Targets Ther 15:953–962. https://doi.org/10.2147/OTT.S365657

5. Santomasso BD, Nastoupil LJ, Adkins S et al (2021) Management of immune-related adverse events in patients treated with chimeric antigen receptor T-cell therapy: ASCO guideline. J Clin Oncol 39:3978–3992. https://doi.org/10.1200/JCO.21.01992

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Daratumumab;Reactions Weekly;2023-04-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3